Prognostic Implications of MALAT1 and BACH1 Expression and Their Correlation with CTCs and Mo-MDSCs in Triple Negative Breast Cancer and Surgical Management Options

Table 9

Summary of surgical management of our cases.

Stage	No	L.N	Size	+ve MALAT1	+ve BACH1	Both -ve	Recurrence	Died	CR	Management
I	12	-ve	<2.5 cm	—	—	12	3	0	9	MRBT
II A	2	-ve	<2.5 cm	—	—	2	1	0	1	MRBT
II A	6	-ve	3-4.5	2	4	2	3	0	3	MRM
II A	5	+ve	1-3.5	—	—	5	0	0	5	MRM
II B	20	+ve or –ve	3-8	8	8	9	9	6	5	MRM
III A	10	+ve or –ve	3-7	7	10	—	7	2	1	MRM
III B	19	+ve or –ve	2.5-6	10	15	4	8	11	0	MRM
III B	4	+ve or –ve	Any size	3	2	1	3	1	0	Neoadjuvant then MRM
IV	10	+ve or –ve	2.5-7	6	9	—	2	8	0	Palliative therapy